Introduction
The mammalian aurora-A has been first identified within the amplicon 20q13 frequently detected in human breast tumours (Tanner et al., 1994 (Tanner et al., , 1995 . Only a partial cDNA encoding a protein kinase was isolated and named BTAK for Breast Tumour Activated Kinase (Sen et al., 1997) . Few years later, a Drosophila gene encoding a kinase homologue was identified and named aurora (Glover et al., 1995) . Many aurora kinases have then been found in various organisms giving birth to as many different confusing names as publications, and Erich Nigg proposed the nomenclature aurora-A, -B and -C (Nigg, 2001) . Aurora-C expression seems to be restricted to spermatogenesis at the time when cells assemble the two meiotic spindles (Hu et al., 2000; Tseng et al., 1998) . Aurora-B is a chromosome passenger involved in cytokinesis and chromosome architecture (Adams et al., 2000 (Adams et al., , 2001 Giet and Glover, 2001) . Aurora-A is a centrosome kinase which function is not yet fully understood. We must say here that although mammalian genomes encode for three different aurora kinases, C. elegans and D. melanogaster genomes encodes for aurora-A and aurora-B paralogue whereas the yeast genomes S. cerevisiae and S. pombe encode for only one aurora kinase (Chan and Botstein, 1993; Petersen et al., 2001) . Although this is only speculation, it seems that at least for yeast the functions of both the mammalian aurora-A and -B is fulfilled by a unique kinase, suggesting that functions have diverged throughout evolution. One must then take carefully the functions described for the yeast aurora kinases and take into account the different localization of aurora-A and aurora-B in mammalian cells. For instance, the yeast aurora substrates found to date are the Ndc10p kinetochore protein, and the histone H3 chromosomal protein whose localization corresponds to the mammalian aurora-B localization. The phosphorylation state of Ndc10p in yeast controls the spindle microtubules attachment to the chromosome kinetochore (Biggins et al., 1999; Sassoon et al., 1999) . In addition, although the exact function of serine 10 phosphorylation in H3 during mitosis remains controversial, it seems to be necessary for chromosome segregation. In multicellular eukaryotes histone H3 have been demonstrated to be an aurora-B substrate by RNA-mediated interference both in C. elegans (Hsu et al., 2000) and in D. melanogaster (Adams et al., 2001; Giet and Glover, 2001 ). Aurora-A phosphorylates the kinesin related protein Eg5 required for both centrosome separation and spindle assembly and stability, just like aurora-A (Giet et al., 1999a) . The kinase also phosphorylates CPEB protein (Cytoplasmique Polyadenylation Element Binding protein), and this phosphorylation induces polyadenylation of mRNA allowing translation during Xenopus oocyte maturation . This mechanism seems to occur locally within the spindle pole in the vicinity of the centrosome (Groisman et al., 2000) . Recently the human TACC3 (Transforming Acidic Coiled Coil protein number 3) has also been found to be phosphorylated by aurora-A. The function of this phosphorylation in D. melanogaster is to recruit the protein to the centrosome (Giet et al., 2002) . This might in fact be one of the major roles of aurora-A; recruiting proteins on the centrosome to fulfil a local function, insuring centrosome maturation for instance (Berdnik and Knoblich, 2002; Hannak et al., 2001) .
In order to better understand what could be the function of aurora-A, in the first part of this review we will describe in a very simplistic way the behaviour and the function of the centrosome during cell cycle. We will then concentrate on the aurora-A kinase itself, its structure, localization and cell cycle behaviour. In a second part, we will focus on the four different functions attributed to aurora-A during cell cycle progression in various organisms. Finally, we will introduce the oncogenic potential of the kinase overexpression. Indeed, the main goal in current aurora-A research is to understand how its amplification leads to cell transformation.
Aurora-A localizes to the centrosome

The centrosome
The centrosome in G1 can be schematically described as an organelle comprising three areas: the two centrioles, the connection between centrioles (the matrix) and the pericentriolar material (PCM) ( Figure  1 ). The centriole is made of nine triplets of microtubules assembled around a 'cartwheel' of unknown composition to form a cylinder. The two centrioles are different, one old 'mother' (with appendages) and one young 'daughter'. The matrix is composed of various proteins that connect the two centrioles in a flexible manner. The composition of the PCM varies along the cell cycle progression with proteins coming and leaving this very active area. In mammalian cells, the major function of the centrosome has long been thought to be only a microtubule organizing centre (MTOC) organizing the interphase microtubule network and the bipolar mitotic spindle. However, the centrosome, at least one of the centrioles, is also implicated in cytokinesis. Indeed, mammalian cells lacking centrosome can assemble a bipolar spindle, but are not able to divide (Bornens, 2002) .
Aurora-A
During the G2 phase of the cell cycle aurora-A colocalizes with g-tubulin in mammalian cells indicating that it is a centrosome protein (Gopalan et al., 1997; Kimura et al., 1997; Roghi et al., 1998) . The protein is also found at the bipolar mitotic spindle poles. However, the immunodetection of aurora-A in cultured cells requires an absence of detergent indicating that the binding of the kinase to the centrosome is weak. At the electron microscopy level aurora-A is mainly found around the PCM (Roghi et al., 1998) and in GFP-centrin transformed cells aurora-A is clearly detected in a quite large area around the two dots corresponding to the centrioles (Figure 1b and personal observation). The localization of aurora-A depends on the cell cycle: the protein is detected by indirect immunofluorescence only on duplicated centrosomes, from the end of S phase to the beginning of the G1 phase of the next cycle (Figure 2a,b) .
The three aurora kinases that show different cellular localization have a conserved catalytic domain (Cterm) and a non-catalytic domain (N-term) different in size and sequence. In the case of aurora-A, both GFPtagged domains localize to centrosomes. However, the centrosome localization of the N-terminal domain depends on the presence of microtubules (active mechanism) whereas the centrosome localization of the C-terminal domain is independent of microtubules (passive mechanism) ). Depolymerization of the microtubules by nocodazole treatment does not remove aurora-A from the centrosome, indicating that its localization can be microtubule independent (Roghi et al., 1998) . The catalytic domain presumably localizes to centrosomes because of its affinity for the kinase substrates . However, its kinase activity is not necessary for centrosome localization, since the kinasedead mutant localizes like the active one (Giet and Figure 1 Localization area of aurora-A at the centrosome. The top panel shows a very simplistic scheme of a centrosome with its two centrioles (in blue); the young one (light blue) and the old one (dark blue) with its appendages (in grey). The connections between the centrioles are represented by a green area and the pericentriolar material in red correspond to aurora-A localization. The lower panel shows an image taken in a cell showing one centrosome (two centrioles) stained with GFP-centrin (green) and an anti-aurora-A antibody (red) . Aurora-A is also thought to be a microtubule-associated protein and binds to taxolstabilized microtubules in vitro (Roghi et al., 1998) .
Aurora-A is degraded by the proteasome and the ubiquitin dependent pathway (Honda et al., 2000; Walter et al., 2000) . Its degradation occurs in early G1, and depends on a degradation box, the sequence RxxLxxG located in the C-terminal end of the protein, targeted by Fizzy-related protein (Arlot-Bonnemains et al., 2001; Castro et al., 2002) (Figure 3 ). Aurora-A kinase activity is activated by phosphorylation of a threonine residue within the activation loop of the kinase catalytic domain (Walter et al., 2000) ( Figure  3 ). Although it seems that the activation depends on cdc2/cyclinB activity, the kinase that phosphorylates aurora-A remains to be found (Frank-Vaillant et al., 2000) .
Aurora-A and centrosome behaviour
Aurora-A localizes to centrosomes immediately after their duplication (end of S phase). The kinase Figure 3 Human aurora-A structure. The kinase catalytic domain is shown in red. It contains an aurora kinase signature (xRxTxCGTx) in the activation loop between subdomains VII and VIII with a threonine whose phosphorylation activates the kinase. It also contains a degradation box (RxxLxG) in its C-terminal end that is targeted by Fizzy-related to induce aurora-A degradation by the ubiquitin dependent pathway and the proteasome. Aurora-A N-terminal domain (in blue) serves as a localization domain to target the protein to the centrosome in a microtubule dependent manner accumulates there until early G1 when it is degraded. During all this period, centrosomes are not allowed to re-duplicate, they must separate and maturate (end of G2/prophase), and they participate to bipolar spindle assembly by nucleating both spindle and astral microtubules in mitosis.
Centriole duplication
Just like DNA replication, centriole duplication depends on the restriction point controlled at the molecular levels by cdk2/cyclinE kinase and the transcription factor E2F (Lacey et al., 1999; Matsumoto et al., 1999; Meraldi et al., 1999) , and begins a little earlier than the G1/S transition before initiation of DNA replication. Before the end of S phase, the cell contains four centrioles forming two unseparated centrosomes (Doxsey, 2001) . This is the time when aurora-A begins to decorate both centrosomes. Thus it seems unlikely that aurora-A is directly involved in centriole duplication.
However ectopic expression of aurora-A in any cultured cells provokes centrosome amplification (Meraldi et al., 2002; Zhou et al., 1998) . Surprisingly, the kinase activity is not required, because overexpression of an aurora-A dead-kinase also leads to centrosome amplification (Meraldi et al., 2002 ; our unpublished observation). How could aurora-A control centrosome amplification? Centrioles start to duplicate while the kinase is not yet detected in the cell. Aurora-A could somehow participate in a cross-talk between the centrosome cycle and the nuclear cycle. The kinase could, for instance, control the 'licence' to duplicate by localizing to centrosomes just after duplication to activate an inhibitor of duplication. Duplication must occur once and only once during the cell cycle, reduplication being allowed only after passage through mitosis. An increased level of active or inactive kinase in cells might be sufficient to deregulate this control.
Centrosome separation
After duplication, centrosomes must separate and migrate around the nuclear envelop to reach (in prophase) opposite positions that will correspond to the bipolar mitotic poles. This movement depends on the presence of microtubules and is under control of molecular motors. Defects in centrosome separation necessarily lead to the formation of a monopolar spindle that is unable to ensure chromosome segregation, inducing abortive mitosis. First described in Drosophila, mutation in aurora-A provokes the apparition of monopolar spindles due to centrosome separation defect and bipolar spindle where one of the poles is formed without centrosome (Glover et al., 1995) . In this case, the opposite pole often contains multiple centrioles suggesting that centrosomes failed to separate and were amplified (Giet et al., 2002) . A role of aurora-A in centrosome separation was confirmed in Xenopus egg extracts, in which inhibition of aurora-A during bipolar spindle formation by addition of an inactive recombinant protein kinase also leads to monopolar spindle (Roghi et al., 1998) . Some of these monopolar spindles seemed to contain two centrosomes that failed to separate (Giet et al., 1999b) . In contrast, during the first mitosis in C. elegans, aurora-A is not required for centrosome separation (Schumacher et al., 1998) , although in the absence of the kinase bipolar mitotic spindles fail to assemble because centrosomes collapse together leading to monopolar spindle formation (Hannak et al., 2001) .
In Xenopus, the kinesin-related protein Eg5 is phosphorylated by aurora-A (Giet et al., 1999) . Eg5 that has been implicated in centrosome separation (Blangy et al., 1995; Sawin et al., 1992; Whitehead and Rattner, 1998; Whitehead et al., 1996) begins to localize precisely between the two duplicated centrosomes decorated by aurora-A at the end of S phase (Giet et al., 1999) . There is no direct proof that aurora-A phosphorylates Eg5 in order to trigger centrosome separation, but inhibition of aurora-A or inhibition of Eg5 leads to a failure to separate centrosomes both in Xenopus (Roghi et al., 1998; Sawin et al., 1992) and in Drosophila (Glover et al., 1995; Heck et al., 1993) . S. cerevisiae possesses only one aurora kinase (Ipl1p), although the majority of ipl1 mutant cells show a normal mitotic spindle, few cells exhibit a monopolar spindle at the restrictive temperature (Kim et al., 1999) . In yeast, the spindle pole bodies (yeast centrosome) separation requires the function of both motor proteins Cin8p (Eg5 homologue) and Kip1p Roof et al., 1992; Saunders and Hoyt, 1992) . It happens that IPL1 and CIN8 are genetically related and that CIN8 gene becomes essential in ipl1 mutants (Geiser et al., 1997; Kim et al., 1999) .
Centrosome maturation
Once duplicated and separated, centrosomes must go through a maturation process that mainly consists of recruiting various proteins that contribute to the structure of the centrosome, and that will also ensure centrosome function during mitosis and the next G1.
In C. elegans g-tubulin and at least two other proteins from the PCM are recruited to the centrosome in an aurora-A dependent manner (Hannak et al., 2001) . In Drosophila D-TACC (Transforming Acidic Coiled Coil) and MSPS (Mini Spindle) do not localize anymore to centrosome in mutant embryos and cultured cells in which aurora-A RNA-mediated interference was performed (Giet et al., 2002) . In Drosophila AurA37 mutant cells, aurora-A mutation lies in the kinase catalytic domain (subdomain III) with a conserved arginine in position 201 replaced by a histidine residue. This mutation affects aurora-A localization that is not detected anymore on the centrosome. In the majority of the mutant cells, gtubulin and centrosomin are not detected on the centrosome, suggesting that aurora-A is required for the recruitment of these proteins on the centrosome (Berdnik and Knoblich, 2002) .
Mitotic spindle
In interphase cells, microtubule array is derived from a single centrosome. At the onset of mitosis, interphasic microtubule array breaks down and duplicated-centrosomes nucleate highly dynamic microtubules that assemble the bipolar spindle. Inhibition of aurora-A activity in Xenopus egg extracts that have already assembled such spindles leads to a destabilization of the structure (Giet and Prigent, 2000) . From a bipolar spindle with chromosomes aligned in the metaphase plate, two rosettes of microtubules surrounded by chromosomes are generated. The whole mechanism seems to correspond to an inhibition of a stabilizing factor that link microtubules together (Giet and Prigent, 2000) . A defect in Eg5 function would explain this phenotype, but other spindle stabilizing proteins are also good candidates. The protein D-TACC, for instance, is a centrosome protein, it associates with microtubules and organizes and/or stabilizes centrosome microtubules in early Drosophila embryos (Gergely et al., 2000a,b) . D-TACC interacts with mini-spindle (MSPS), a microtubule associated protein also required for the integrity of the spindle (Cullen et al., 1999; Lee et al., 2001) . Interestingly, in Drosophila aurora-A mutant cells, D-TACC and MSPS proteins are reduced at the poles of the mitotic spindle (Giet et al., 2002) . Furthermore, aurora-A phosphorylates D-TACC and both protein co-immunoprecipitates. The interaction is conserved in human in which aurora-A interacts with TACC3 (Giet et al., 2002) . In addition to a mis-localization of proteins, Drosophila aurora-A mutant shows a reduction in astral microtubules associated with a reduction in the spindle length. D-TACC could be considered as a regulatory subunit targeted to the centrosome by aurora-A and MSPS a catalytic subunit, which stabilizes microtubules. The same defects have been observed in C. elegans after elimination of aurora-A by RNA interference (Schumacher et al., 1998) . Loss of aurora-A expression results in the assembly of a spindle with few and short microtubules. Centrosomes in these embryos also display defects in microtubule nucleation activity (Schumacher et al., 1998; Hannak et al., 2001 ).
Aurora-A overexpression, cancer and centrosome amplification
Aurora-A gene lies in the 20q13 amplicon Aurora-A gene is located in the 20q13 chromosome region that is frequently amplified in several different types of malignant tumours such as colorectal, breast and bladder cancers (Bischoff et al., 1998; Zhou et al., 1998) . In breast cancer cells in particular, the 20q11-q13 region is amplified in 40% of cancer cell lines as well as in 12 to 18% of primary tumours. The incidence increases to 60% in breast cancers with familial predisposition due to a mutation of the BRCA2 gene (Tirkkonen et al., 1997) . Moreover, amplification of the 20q13 region is associated to a bad prognosis in adenopathy free breast cancers . In gastric cancers, amplification of the 20q13 region is detected by Southern blot in 5% (4/72) of the cases with amplification from 3.5 -6.3-fold. In contrast, amplification of the 20q13 region is found by FISH analysis in 34/72 of the cases. Amplification was high in four cases (5%), moderated in 11 cases (15%) and low in 19 cases (28%) (Sakakura et al., 2001) . The 20q13 amplification is also detected in 52% (41/79) of primary colorectal tumours (Bischoff et al., 1998) .
Aurora-A mRNA and protein overexpression
Aurora-A mRNA overexpression correlates with the presence of the 20q13 amplicon. In primary colorectal tumours, mRNA expression increases from 4 -28-fold in 54% (22/41) (Bischoff et al., 1998) . Overexpression also occurs in gastric cancer cell lines as well as in 18 of 35 primary gastric cancers (Sakakura et al., 2001) . At the immunohistochemical level aurora-A is overexpressed in 94% (31/33) of primary invasive mammary carcinomas irrespective of their histopathological types. Moreover, the aurora-A staining in these cases is found diffusely in cytoplasm, and not restricted to centrosomes. Aurora-A is undetectable in normal mammary tissues or in necrotic cancer cells . Interestingly, aurora-A overexpression is significantly associated with primary tumour invasiveness and p53 accumulation (Takahashi et al., 2000) .
Aurora-A, ploidy and cancer
The more frequent genomic damage that occurs during cancer development is chromosomal instability that involves gains and losses of pieces of chromosomes or whole chromosomes (Lengauer et al., 1998) . A great number of published works show that aneuploidy is a good marker of tumour progression and prognosis. Bladder carcinoma are detected by measuring urine cytology DNA for instance (Klein et al., 1982) . Furthermore, in gastric carcinoma (Sasaki et al., 1999) and in papillary thyroid carcinoma (Sturgis et al., 1999) aneuploidy is a marker of metastasis and in many malignancies aneuploidy is associated with a poor outcome (Abad et al., 1998; Magennis, 1997; Sasaki et al., 1999) . A correlation between aurora-A overexpression and aneuploidy exists in gastric cancer. Indeed, clinical samples with aurora-A amplification and overexpression show aneuploidy and poor prognosis (Sakakura et al., 2001) .
Aurora-A, centrosome aberrations and cancer
Usually cells become aneuploid because of aberrant or abortive mitosis. It can be a consequence of a centrosome duplication cycle defect that would lead to an abnormal mitotic spindle assembly and a failure in correctly segregating chromosomes. Such errors might contribute to cancer appearance by generating a genetic instability, increasing the risk for a cell to gain genes involved in proliferation or to lose tumour suppressor genes. Interestingly despite the fact that centrosome amplification is not the only centrosome abnormality found in solid tumours, it has become, just like polyploidy, a signature for many tumours. Indeed, centrosome aberrations are found in brain (Pihan et al., 1998; Weber et al., 1998) , breast (Lingle et al., 1998; Lingle and Salisbury, 1999; Pihan et al., 1998) , lung, colon, prostate (Pihan et al., 1998) , pancreas (Sato et al., 1999) , bile duct (Kuo et al., 2000) , head and neck (Gustafson et al., 2000) .
Numbers of centrosome alterations are observed in tumours such as supernumerary centrioles, abnormal centrosome number or volume, centrosome protein phosphorylation modification, accumulation of an excess of pericentriolar material etc. (Lingle et al., 1998; Pihan et al., 1998) . All those centrosome alterations might lead to bipolar mitotic spindle defects, chromosomal segregation deficiency and aneuploidy. Although no direct link has been found between aurora-A overexpression and centrosome abnormalities in cancer, aurora-A overexpression, centrosome amplification and aneuploidy are always associated. Furthermore, centrosome aberrations are known to lead to aneuploidy, suggesting that aurora-A overexpression which is responsible for centrosome amplification must participate in tumorigenesis in a particular genetic background.
Aurora-A ectopic overexpression in cell lines
Many experiments have demonstrated the requirement of aurora-A in centrosome regulation. In Drosophila, Aurora-A mutants show several centrosome defects that were confirmed by RNA-mediated interference (RNAi) (Giet et al., 2002; Glover et al., 1995) . Aurora-A overexpression in cell lines leads to centrosome amplification, multipolar spindle and polyploidy (Bischoff et al., 1998; Zhou et al., 1998) (Figure 4) . Overexpression of wild type aurora-A or a constitutively active mutant of the kinase in Rat1 or NIH3T3 cells leads to a higher number of colonies growing in soft agar. That was not the case when an inactive mutant aurora-A was overexpressed. Moreover, Rat1 cells transformed with active aurora-A show tumour growth in nude mice, demonstrating that aurora-A is an oncogene (Bischoff et al., 1998) .
Transient expression of active aurora-A in the near diploid human breast epithelial cell line MCF10A leads to aberrant chromosome segregation and an increase in ploidy (Zhou et al., 1998) . In contrast, a C-terminaldeleted mutant of aurora-A induces no effect in the ploidy state of transfected gastric cancer cells, but inhibits cell proliferation (Sakakura et al., 2001 ). However, surprisingly, an inactive aurora-A kinase produces virtually identical phenotypes to the wild-type active kinase when overexpressed in Chinese hamster ovary (CHO) cells (Meraldi et al., 2002) . Both transfected cells exhibit extra copies of centrosomes. However such inactive aurora-A is unable to transform Rat1 or NIH3T3 cells, strongly indicating that (1) a gain of aurora-A kinase activity is necessary to transform cells, and (2) that centrosome amplification is not sufficient to provoke transformation (Bischoff et al., 1998) (Figure 5 ). Thus, overexpression of the aurora-A kinase is able to induce centrosome amplification, but its kinase activity is not necessary to obtain Figure 4 Overexpression of wild type GFP-aurora-A in MCF10A cells. Top panel: interphase cell with centrosome amplification, the green dots correspond to aurora-A/centrosome localization. lower panel: a metaphase cell with a multipolar spindle. DNA stained with DAPI appears in blue this phenotype. Maybe the accumulation of the protein leads to a disorganization of the centrosome machinery unrelated to its catalytic function but caused by a steric accumulation that interferes with the centrosomal functions.
In contrast, the kinase activity of aurora-A is necessary to obtain the transformed phenotype by overexpression in cultured cells. Thus centrosome amplification induced by aurora-A overexpression is not sufficient for its oncogenic activity. Under overexpression, aurora-A might phosphorylate substrates unrelated to the centrosome function but involved in oncogenesis. Not all cell lines are transformed by aurora-A overexpression. Then, as suggested by Bischoff et al. (1998) , it is possible that overexpression of aurora-A is transforming only in the presence of coamplification or mutation in additional genes that could be involved in a process supposed to eliminate cells with aberrant DNA content, just as in p537/7 cells (Meraldi et al., 2002) .
Aurora-A: a proliferation marker?
The high correlation between aurora-A, high histoprognostic grade, aneuploidy makes the kinase a potential prognostic factor. In breast cancer less than half of cancer cells are PCNA positive (Proliferating Cell Nuclear Antigen) despite the fact that they are all aurora-A positive (490%) . In primary colorectal tumours as well as in breast cancer Figure 5 Overexpression of aurora-A, centrosome amplification and tumorogenesis. Overexpression of either the active or inactive aurora-A-GFP provokes centrosome amplification in any cell line. Duplicated (amplified) centrosomes appear in green. Only overexpression of the active kinase and in particular cell lines is sufficient to obtain a transformed phenotype (in red) no correlation was found between aurora-A and PCNA expression (Takahashi et al., 2000; . In contrast to PCNA that is a wellestablished and routinely used proliferation marker, aurora-A would rather be a malignancy marker that should also be useful in treatment choice. For instance, the inhibition of the kinase activity could help to reduce tumour aggressiveness in addition to commonly used chemotherapeutic drugs.
